Kathleen L Ruchalski (Kathleen Ruchalski)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Drug Administration

Radical Prostatectomy

Metastatic Renal Cell Carcinoma

Prostate Cancer

Top Venues

Radiology. Imaging cancer

Cancer imaging : the official publication of the International Cancer Imaging Society

This page only lists publications with an associated author ORCID identifier.

Publications

Sean Johnson, Matthias R Benz, Kathleen L Ruchalski
Carcinoid Heart Disease. Radiology. Imaging cancer 6 (1) (2024)
Sean Johnson, Matthias R Benz, Kathleen L Ruchalski
Carcinoid Heart Disease. Radiology. Imaging cancer 6 (1) (2024)
Sean Johnson, Matthias R Benz, Kathleen L Ruchalski
Carcinoid Heart Disease. Radiology. Imaging cancer 6 (1) (2024)
Sean Johnson, Matthias R Benz, Kathleen L Ruchalski
Carcinoid Heart Disease. Radiology. Imaging cancer 6 (1) (2024)
Daniel J A Margolis, Kathleen L Ruchalski
Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations? Radiology. Imaging cancer 5 (5) (2023)
Amanda J Gong, Kathleen L Ruchalski, Grace Hyun J Kim, Michael L Douek, Antonio Gutierrez, Maitraya K Patel, Victor Sai, Heidi Coy, Bianca Villegas, Steven S Raman, Jonathan Goldin
RECIST 1.1 Target Lesion Categorical Response in Metastatic Renal Cell Carcinoma: A Comparison of Conventional versus Volumetric Assessment. Radiology. Imaging cancer 5 (5) (2023)
Kathleen L Ruchalski, Hyun J Kim, Michael Douek, Steven Raman, Maitraya Patel, Victor Sai, Antonio Gutierrez, Benjamin Levine, Cheryce Fischer, Martin Allen-Auerbach, Pawan Gupta, Heidi Coy, Bianca Villegas, Matthew Brown, Jonathan Goldin
Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression. Cancer imaging : the official publication of the International Cancer Imaging Society 22 (1) (2022)
Kathleen L Ruchalski, Marta Braschi-Amirfarzan, Michael L Douek, Victor Sai, Antonio Gutierrez, Rohit Dewan, Jonathan Goldin
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials. Radiology. Imaging cancer 3 (3) (2021)
Heidi J Coy, Michael L Douek, Kathleen L Ruchalski, Grace Hyun J Kim, Antonio Gutierrez, Maitraya K Patel, Victor Sai, Daniel J A Margolis, Andrew Kaplan, Matthew S Brown, Jonathan Goldin, Steven S Raman
Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma. Radiology 292 (1) (2019)